COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 179 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $509,603 | +28.6% | 22,801 | +23.6% | 0.00% | – |
Q2 2023 | $396,362 | -98.4% | 18,444 | -98.5% | 0.00% | -100.0% |
Q4 2020 | $25,145,000 | -27.5% | 1,255,371 | -24.6% | 0.01% | -35.3% |
Q3 2020 | $34,684,000 | +19.2% | 1,665,872 | +0.1% | 0.02% | +13.3% |
Q2 2020 | $29,099,000 | -2.6% | 1,664,663 | -9.0% | 0.02% | -25.0% |
Q1 2020 | $29,881,000 | -18.0% | 1,829,772 | +3.4% | 0.02% | +5.3% |
Q4 2019 | $36,429,000 | +70.3% | 1,770,152 | -5.0% | 0.02% | +58.3% |
Q3 2019 | $21,387,000 | -12.4% | 1,862,971 | +0.4% | 0.01% | -7.7% |
Q2 2019 | $24,404,000 | -12.1% | 1,855,845 | +1.2% | 0.01% | -13.3% |
Q1 2019 | $27,764,000 | -11.8% | 1,833,838 | -0.0% | 0.02% | -21.1% |
Q4 2018 | $31,495,000 | +21.4% | 1,834,289 | +4.3% | 0.02% | +46.2% |
Q3 2018 | $25,935,000 | -23.0% | 1,759,506 | +24.6% | 0.01% | -23.5% |
Q2 2018 | $33,686,000 | -10.3% | 1,412,442 | -3.9% | 0.02% | -10.5% |
Q1 2018 | $37,535,000 | +34.5% | 1,469,119 | -2.8% | 0.02% | +46.2% |
Q4 2017 | $27,907,000 | +19.1% | 1,511,775 | -32.3% | 0.01% | +18.2% |
Q3 2017 | $23,426,000 | -15.0% | 2,233,147 | +1.3% | 0.01% | -21.4% |
Q2 2017 | $27,569,000 | +22.8% | 2,203,781 | -1.2% | 0.01% | +27.3% |
Q1 2017 | $22,446,000 | -19.8% | 2,231,203 | +24.1% | 0.01% | -21.4% |
Q4 2016 | $27,994,000 | +60.2% | 1,797,902 | +98.2% | 0.01% | +55.6% |
Q3 2016 | $17,469,000 | +63.1% | 907,034 | +0.4% | 0.01% | +50.0% |
Q2 2016 | $10,708,000 | -28.9% | 903,602 | +8.9% | 0.01% | -25.0% |
Q1 2016 | $15,057,000 | +68.8% | 829,599 | +155.8% | 0.01% | +60.0% |
Q4 2015 | $8,919,000 | +20.3% | 324,300 | -3.3% | 0.01% | +25.0% |
Q3 2015 | $7,413,000 | +25.7% | 335,300 | +1.4% | 0.00% | +33.3% |
Q2 2015 | $5,898,000 | – | 330,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |